Related Experiment Videos

Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study

Ioanna Tzoulaki1, Gordon D Murray, Jacqueline F Price

  • 1Wolfson Unit for Prevention of Peripheral Vascular Diseases, School of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland, UK. I.Tzoulaki@sms.ed.ac.uk

Insights

Inflammation, not hypercoagulation, appears more linked to atherosclerosis progression. Key markers like fibrinogen and D-dimer showed associations, but inflammation markers like C-reactive protein and interleukin-6 explained these links.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Immunology

Background:

  • Atherosclerosis development involves complex interactions between hemostatic and inflammatory pathways.
  • Understanding these interactions is crucial for identifying therapeutic targets and predicting disease progression.

Purpose of the Study:

  • To investigate the independent and combined associations of hemostatic and inflammatory markers with peripheral atherosclerotic progression.
  • To determine whether inflammation or hypercoagulation is more strongly associated with atherosclerosis.

Main Methods:

  • The Edinburgh Artery Study cohort (1,592 participants, aged 55-74) measured baseline levels of fibrinogen, D-dimer, von Willebrand factor, and inflammatory markers (CRP, IL-6).
  • Ankle-brachial index (ABI) was assessed at baseline and after 12 years to track peripheral atherosclerotic progression.
  • Statistical analyses examined associations between hemostatic/inflammatory markers and ABI change, adjusting for cardiovascular risk factors.

Main Results:

  • Fibrinogen and D-dimer showed significant associations with ABI decline, independent of baseline ABI and cardiovascular risk factors.
  • These associations became non-significant after adjusting for C-reactive protein (CRP) or interleukin-6 (IL-6).
  • Elevated levels of both D-dimer and IL-6 were linked to the most substantial ABI decline, suggesting a combined inflammatory and hemostatic effect.

Conclusions:

  • Fibrinogen and D-dimer are associated with peripheral atherosclerosis progression, but this relationship is mediated by inflammatory processes.
  • Inflammation, indicated by CRP and IL-6, appears to be more fundamentally linked to atherosclerosis than hypercoagulation.
  • These findings support the hypothesis that inflammation plays a more dominant role in atherosclerosis than increased blood clotting tendency.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...